About us

Linking global  personalized medicine

Biona AI is developing software that empowers individuals to follow and understand their personal medical and biometric information, and provides insight into health risk factors and potential therapeutic interventions that may lead to improved outcome and life extension.

The universe of medical and biometric information for an individual is defined as their Biona. The ability to provide this information has been limited my numerous factors:

Confidentiality.

Personal medical information is confidential, and this confidentiality is protected by law. Only the subject and their designated medical professionals are granted access to this information, and its use, when the subject’s permission is granted, must be dissociated from their personal identification. HIPPA regulations govern this process.

Uncorrelated data repositories.

Uncorrelated repositories exist for a subject’s individual records, including your current physician’s records, your dentist’s records, those of specialists you have visited, data from clinical studies you may have participated in, laboratory results performed by clinical laboratories, biological samples in repositories, genetic sequencing data, other genetic testing results, fertility testing results, auditory test results, fingerprints, genealogy records, family health history, vaccine records, X-rays, NMR and PET scans, previous medical and surgical records, emergency room visits, ICU records, psychiatric evaluations and therapies, and data that is only currently available on paper medical charts.

Data security.

Databases are increasingly targets of security breaches. This information can be stolen, corrupted, deleted or materially altered.Big data. Total Biona scale extends to the terabyte range for individual subjects. Consider the enormity of a repository for billions of subjects. This is currently an impossible challenge for relational databases.

Big data.

Total Biona scale extends to the terabyte range for individual subjects. Consider the enormity of a repository for billions of subjects. This is currently an impossible challenge for relational databases.

Individual access and interpretation of their own data.

Due to the enormity and complexity of an individual’s Biona, individual access and interpretation is currently virtually impossible. Subjects should be able to review, query and understand the information securely, easily, and via an artificial intelligence platform that could protect anonymity. This platform would need to be able to describe results in a manner understandable to non-scientific subjects.

Lack of accurate risk predictions based on incomplete data.

Current diagnoses, risk assessments and treatment plans are usually not based on complete genetic and family history information, nor are they always consistent with start-of-the-art testing, diagnosis and therapeutic options.

Lack of widespread, simple biosensors for collection of biometric and biomarker data.

This lack of available biosensors limits the available information for risk assessment, diagnosis, disease staging, therapeutic option assessment, and evaluation of efficacy or chosen therapies.

Lack of availability of equivalent in health care in underprivileged populations.

This deficiency is the most serious limitation to delivering personalized medicine globally.

Confidentiality

By using proprietary advanced blockchain technology, confidential individual ownership of personal Biona can only be accessed by the subscriber, or their designated physician. Subscribers will access their Biona via an individual data key.

Correlated repository

A correlated repository at this scale is only possible by designing a repository of repositories. An individual’s data key access the blockchain repository. The data is not distributed throughout the disseminated servers, only secure data keys linking the location of the individuals Biona data on specific servers.

Data security

Bitcoin technology has demonstrated the ability of blockchain technology to deposit, store and retrieve information in the financial sectors.

Big Data

The repository of repositories structure of Biona AI allows individuals to access their Biona on a platform with a small digital footprint.

Access and interpretation

The current physician lacks the training and expertise to interpret an individual’s Biona and predict outcomes, explain global disease risks, and search for new therapies, based on big data. AI is replacing both the general practitioner and the specialist. Blockchain access to an individual’s Biona allows AI assessment of these crucial medical parameters.

Lack of accurate risk predictions based on incomplete data

Accurate Personalized Medicine requires access and AI interpretation of the complete Biona.

Lack of a simple widespread biosensor application

Personalized Medicine centers are required, disseminated throughout the world to obtain biosensor information assessment and archiving. Underprivileged countries can only be brought up to speed with the dedicated application of resources to local Personalized Medical Centers. A share of the profits from the Biona AI will be dedicated to forging collaborations between Personalized Medicine Organizations, Foundations and Governments to organize worldwide Personalized Medicine Centers. The promise will be improved world health, increased equality in healthcare, and global improvements in nutrition and mental health. The development of biosensors on a global scale accelerates the acquisition and use of biomarkers. This drives scientific development of new therapeutics that can alter outcomes.

As an example, Biona AI is supporting the development of cardiovascular biomarkers and requisite therapeutics for myocardial infarction under the Biona CV program. The information obtained will feedback into the risk assessment and therapeutic options for cardiovascular disease.

Biona AI has a global view of Personalized Medicine. Through development of an international corporation Biona AI can serve as a commercial conduit for linking Personalized Medicine Globally. By investing in the Biona AI corporation, shareholders will also be contributing to supporting global Personalized Medicine centers. Biona AI plans to support International Symposia to discuss the development of the Personalized Medicine centers.

Biona AI

The universe of medical and biometric information for an individual

Linking global personalized medicine

Contacts

Linking global  personalized medicine